V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003381 | 320004997 | 0 | 68 | Palliative (P) | 2018-06-22 | 2018-07-08 | CETUXIMAB + CISPLATIN + FU | 02 | N | 320020589 | CISPLATIN + GEMCITABINE |
| 320003382 | 320004997 | null | 77 | Curative (C) | 2013-04-23 | 2013-04-29 | CARBOPLATIN + RT | 02 | N | 320020589 | TEMOZOLOMIDE |
| 320003386 | 320002044 | 1.67 | 75.7 | Adjuvant (A) | 2014-12-03 | 2014-12-14 | PEMBROLIZUMAB | N | N | 320020652 | CISPLATIN + GEMCITABINE |
| 320003387 | 320004999 | 1.61 | 73 | Adjuvant (A) | 2017-07-22 | 2017-07-22 | Cyclophosphamide PO +Vinorelbine IV | N | N | 320020653 | POUT TRIAL |
| 320003388 | 320004999 | 1.53 | 85 | Adjuvant (A) | 2015-02-04 | 2015-03-02 | Hydroxycarbamide | 2 | N | 320020653 | IMATINIB |
| 320003389 | 320002045 | 1.63 | 77.9 | Neo-adjuvant (N) | 2015-10-08 | 2015-11-27 | Trial Unspecified | N | N | 320020677 | BEVACIZUMAB |
| 320003390 | 320002046 | 1.58 | null | Curative (C) | 2017-08-01 | 2017-08-10 | CISPLATIN + GEMCITABINE | 02 | N | 320020692 | HYDROXYCARBAMIDE |
| 320003391 | 320002047 | null | 68 | Disease modification (D) | null | 2013-05-13 | ICON8 TRIAL | null | null | 320020709 | CISPLATIN + GEMCITABINE |
| 320003392 | 320002047 | 0 | 83.4 | Palliative (P) | 2015-11-17 | 2015-12-04 | Oxaliplatin + Modified de Gramont | Y | N | 320020709 | OXALIPLATIN + MDG |
| 320003394 | 320002049 | 1.66 | 63.3 | Disease modification (D) | null | 2015-01-22 | BCG Intravesical | N | N | 320020735 | CHOP R |
| 320003395 | 320005001 | 1.79 | null | Palliative (P) | 2012-11-11 | 2012-11-16 | ECX | N | N | 320020737 | CARBOPLATIN + CETUXIMAB + FU |
| 320003396 | 320005001 | 1.68 | 53 | Palliative (P) | 2015-05-14 | 2015-05-14 | Trial Unspecified | N | N | 320020737 | CISPLATIN + GEMCITABINE |
| 320003397 | 320002050 | 1.6 | 51.4 | Curative (C) | 2014-04-23 | 2014-05-14 | CARBOPLATIN + ETOPOSIDE | 2 | N | 320020746 | CAPECITABINE + CISPLATIN |
| 320003398 | 320002051 | 1.81 | 67.8 | Palliative (P) | 2016-12-21 | 2017-01-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320020747 | FLUOROURACIL + MITOMYCIN + RT |
| 320003399 | 320002052 | 0 | 84.1 | Palliative (P) | 2018-07-26 | 2018-08-08 | TIP | 2 | N | 320020748 | CARBOPLATIN + RT |
| 320003400 | 320002053 | 1.69 | 93.9 | null | 2016-01-27 | 2016-01-27 | BCG Intravesical | 1 | null | 320020758 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003402 | 320002054 | 1.61 | 85.4 | Neo-adjuvant (N) | 2014-09-28 | 2014-10-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320020760 | CARBOPLATIN + RT |
| 320003404 | 320002056 | 1.67 | 82.2 | Neo-adjuvant (N) | 2013-12-24 | 2014-01-14 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 320020793 | CETUXIMAB |
| 320003405 | 320002057 | 1.75 | 61 | Palliative (P) | 2014-06-28 | 2014-07-12 | CARBO + FLUOROURACIL | N | N | 320020795 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 320003406 | 320002058 | 1.52 | 65 | Disease modification (D) | 2016-03-13 | 2016-03-16 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320020808 | CISPLATIN + GEMCITABINE |
| 320003407 | 320005003 | 1.59 | 62.6 | Palliative (P) | 2013-10-04 | 2013-10-04 | PEMBROLIZUMAB | 02 | N | 320020819 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003409 | 320002060 | 1.82 | 81 | Adjuvant (A) | 2016-01-07 | 2016-08-19 | Dacarbazine | 02 | N | 320020836 | CAP |
| 320003411 | 320002061 | 1.48 | 81 | Palliative (P) | 2015-09-30 | 2015-09-30 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 320020845 | PEMBROLIZUMAB |
| 320003412 | 320002061 | 1.8 | 77 | Curative (C) | 2014-04-01 | 2014-04-01 | Cetuximab + Radiotherapy Load | Y | N | 320020845 | CETUXIMAB + RT |
| 320003413 | 320002061 | 1.64 | null | Palliative (P) | 2017-07-30 | 2017-08-15 | ICON8B TRIAL | Y | null | 320020845 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003414 | 320002062 | 1.82 | 49 | Adjuvant (A) | 2014-03-11 | 2014-03-11 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 320020888 | CARBOPLATIN + DOCETAXEL |
| 320003415 | 320002063 | 1.6 | 55.8 | Adjuvant (A) | 2017-08-16 | 2017-08-29 | ICON8 TRIAL | N | N | 320020889 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003416 | 320002063 | 1.74 | 83 | Curative (C) | 2013-06-30 | 2013-07-07 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320020889 | IMATINIB |
| 320003417 | 320002064 | null | 84.3 | Palliative (P) | 2017-04-09 | 2017-04-14 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320020915 | ATEZOLIZUMAB |
| 320003418 | 320002065 | 1.65 | 56.6 | Palliative (P) | 2016-06-20 | 2016-06-20 | Bevacizumab 7.5mg/kg | N | N | 320020918 | DOCETAXEL + GEMCITABINE |
| 320003420 | 320002067 | 1.66 | 51.9 | Adjuvant (A) | null | 2016-12-22 | CYCLOPHOSPHAMIDE | N | N | 320020924 | ICON TRIAL |
| 320003424 | 320006342 | 1.78 | 76.2 | Palliative (P) | 2015-06-05 | 2015-06-16 | BORTEZOMIB + THALIDOMIDE | N | N | 320020949 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003425 | 320002070 | 1.89 | 97.4 | Palliative (P) | 2017-04-14 | 2017-04-26 | CARBOPLATIN + VINORELBINE | 02 | N | 320020956 | CISPLATIN + GEMCITABINE |
| 320003426 | 320002070 | 0 | 78.4 | Palliative (P) | 2013-03-25 | 2013-04-14 | CETUXIMAB | 02 | N | 320020956 | CISPLATIN + GEMCITABINE |
| 320003427 | 320006343 | 1.53 | 71.2 | Palliative (P) | 2014-11-02 | 2014-11-18 | Bevacizumab 7.5mg/kg | N | N | 320020984 | CAPECITABINE + CISPLATIN |
| 320003428 | 320006343 | null | 96.7 | Disease modification (D) | 2014-11-03 | 2016-07-21 | BCG Intravesical | N | N | 320020984 | CISPLATIN + FLUOROURACIL + RT |
| 320003431 | 320006344 | 1.79 | 72.4 | Disease modification (D) | 2014-09-18 | 2014-10-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320021009 | CARBOPLATIN + ETOPOSIDE |
| 320003432 | 320002072 | 1.68 | null | null | 2013-11-19 | 2013-11-27 | CETUXIMAB | N | null | 320021011 | IPILIMUMAB |
| 320003436 | 320002075 | 1.78 | 88.7 | Curative (C) | 2014-02-01 | 2014-02-20 | ECX | N | N | 320021086 | BCG |
| 320003437 | 320002076 | 0 | 45.2 | Palliative (P) | 2015-05-06 | 2017-11-07 | Doxorubicin + Ifosfamide | 02 | N | 320021098 | CISPLATIN + FLUOROURACIL + RT |
| 320003438 | 320002077 | 1.76 | 104 | Palliative (P) | 2017-07-24 | 2017-08-03 | TEMOZOLOMIDE | Y | N | 320021101 | TIP |
| 320003441 | 320002078 | 1.63 | 55.8 | Curative (C) | 2016-11-03 | 2016-11-20 | Bevacizumab 7.5mg/kg | 2 | Y | 320021110 | PEMBROLIZUMAB |
| 320003442 | 320002078 | 1.59 | 93.2 | null | 2017-11-11 | 2017-11-11 | IPILIMUMAB + NIVOLUMAB | N | N | 320021110 | CARBOPLATIN + VINCRISTINE |
| 320003443 | 320002079 | 1.55 | 82 | Neo-adjuvant (N) | 2013-07-02 | 2013-07-02 | Capecitabine | 02 | N | 320021121 | CARBO + FLUOROURACIL |
| 320003444 | 320002080 | 1.62 | 63 | Adjuvant (A) | null | 2016-08-24 | Trial Unspecified | null | null | 320021122 | CISPLATIN + GEMCITABINE |
| 320003446 | 320002081 | 1.79 | 95.4 | Curative (C) | 2017-03-20 | 2017-05-09 | TEMOZOLOMIDE | N | N | 320021135 | CARBOPLATIN + RT |
| 320003447 | 320002082 | 1.79 | 92.8 | Palliative (P) | 2014-07-11 | 2014-07-26 | Mitomycin Intravesical | N | N | 320021153 | CISPLATIN + GEMCITABINE |
| 320003448 | 320002083 | 1.76 | 24.5 | null | 2017-05-27 | 2017-06-08 | EVEROLIMUS | N | N | 320022665 | IVA |
| 320003449 | 320002083 | 1.64 | 59.8 | Adjuvant (A) | 2017-06-03 | 2017-07-06 | Cisplatin + Vinorelbine (IV) | 2 | Y | 320022665 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003450 | 320002083 | null | 68 | Curative (C) | null | 2013-05-24 | CVP R | N | N | 320022665 | CARBOPLATIN + VINCRISTINE |